Global Health Data Exchange - Discover the World's Health Data

Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden

Nav

General Info
Geography 
Afghanistan (AFG)
Angola (AGO)
Armenia (ARM)
Azerbaijan (AZE)
Bangladesh (BGD)
Benin (BEN)
Bhutan (BTN)
Bolivia (BOL)
Burkina Faso (BFA)
Burundi (BDI)
Cambodia (KHM)
Cameroon (CMR)
Central African Republic (CAF)
Chad (TCD)
Comoros (COM)
Congo (COG)
Cuba (CUB)
Côte d'Ivoire (CIV)
Democratic Republic of the Congo (COD)
Djibouti (DJI)
Eritrea (ERI)
Ethiopia (ETH)
Gambia (GMB)
Georgia (GEO)
Ghana (GHA)
Guinea (GIN)
Guinea-Bissau (GNB)
Guyana (GUY)
Haiti (HTI)
Honduras (HND)
India (IND)
Indonesia (IDN)
Kenya (KEN)
Kiribati (KIR)
Kyrgyzstan (KGZ)
Lao People's Democratic Republic (LAO)
Lesotho (LSO)
Liberia (LBR)
Madagascar (MDG)
Malawi (MWI)
Mali (MLI)
Mauritania (MRT)
Mongolia (MNG)
Mozambique (MOZ)
Myanmar (MMR)
Nepal (NPL)
Nicaragua (NIC)
Niger (NER)
Nigeria (NGA)
Pakistan (PAK)
Papua New Guinea (PNG)
Republic of Korea (KOR)
Republic of Moldova (MDA)
Rwanda (RWA)
Sao Tome and Principe (STP)
Senegal (SEN)
Sierra Leone (SLE)
Solomon Islands (SLB)
Somalia (SOM)
Sri Lanka (LKA)
Sudan (SDN)
Tajikistan (TJK)
Timor-Leste (TLS)
Togo (TGO)
Uganda (UGA)
Ukraine (UKR)
United Republic of Tanzania (TZA)
Uzbekistan (UZB)
Viet Nam (VNM)
Yemen (YEM)
Zambia (ZMB)
Zimbabwe (ZWE)
View all
Time period covered 
01/2009 - 12/2010
Data type
Scientific literature
Keywords 
HPV, HPV vaccines, Preventive interventions, Rotavirus
GHDx Entry last modified on: Jan 31, 2023